Skip to content
OpenCapital
Get started

Maravai LifeSciences Holdings, Inc. MRVI UNITED STATES — Revenue

Similar metrics at other companies

10x Genomics, Inc. logo
TXGUnited States — Revenue
$76.69M-11.7%
Alpha and Omega Semiconductor logo
AOSLUNITED STATES — Revenue
$2.15M+84.3%
Guardant Health logo
GHUnited States — Revenue
$284.63M+47.0%
Azenta logo
AZTAUnited States — Total Revenue
$83.02M-7.7%
Veracyte logo
VCYTUnited States — Total Revenue
$124.15M+17.3%
Silicon Laboratories logo
SLABUnited States — Revenue
$17.96M+7.6%

Other financials

Income statement

See full
Revenue$65.8M+40.5%
Gross profit$33.7M+336%
Operating income-$2.2M+95.6%
Net income-$3.7M+87.5%
EPS (diluted)-$0.02+90.5%

Balance sheet

See full
Cash & equivalents$165.9M-41.8%
Total debt$270.9M-17.1%
Total equity$211.6M-29.6%
Total assets$713.2M-25.7%

Cash flow

See full
Operating cash flow$8.7M+192%
CapEx$4.4M-1.4%
Free cash flow$4.2M+130%

Valuation

See full
Market cap$849.64M+186%
Enterprise value$954.59M+182%
P/S4.2×+2.9×

Profitability

See full
Gross margin29.3%-8.0pp
Operating margin-82.2%-16.6pp
Net margin-51.1%-9.9pp
FCF margin-25.7%—

Returns & leverage

See full
Return on equity-40.8%-4.0pp
Debt / equity1.3×+0.2×
Current ratio5.9×-0.1×

Where this comes from

Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Maravai LifeSciences Holdings, Inc.'s united states — revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Maravai LifeSciences Holdings, Inc.'s UNITED STATES — revenue?
Maravai LifeSciences Holdings, Inc. (MRVI) reported UNITED STATES — revenue of $35.2M in Q1 2026.
How has Maravai LifeSciences Holdings, Inc.'s UNITED STATES — revenue changed year-over-year?
Maravai LifeSciences Holdings, Inc.'s UNITED STATES — revenue increased by 22.2% year-over-year, from $28.8M to $35.2M.
What does UNITED STATES — revenue mean?
This metric represents the total revenue generated from sales of nucleic acid production and biologics safety testing products to customers located within the United States. It serves as a key indicator of the company's market penetration and demand for its life sciences research and therapeutic manufacturing solutions in the domestic market. Tracking this geographic revenue stream helps investors assess the company's reliance on the U.S. healthcare and biotechnology research landscape.